Recently, other clinical features have been described, including coagulopathies (due to reduced levels of platelets and fibrinogen), higher levels of lactate dehydrogenase (LDH), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) whose role within the intraindividual clinical evolution of COVID-19 and its severity still need to be clarified (10). This evidence concerns the gene GPT and COVID-19.